New strategy aims to unlock full power of heart meds for elderly patients

NCT ID NCT06578078

Summary

This study is testing if a drug called Lokelma (SZC), which lowers potassium, can help elderly patients with both heart failure and chronic kidney disease safely take higher, more effective doses of their standard heart medications. Many patients cannot take the full recommended dose of these life-saving drugs because high potassium is a common side effect. Researchers will compare patients who receive Lokelma while their heart meds are increased to those who get standard care without it.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Clínico Universitario de Valencia

    RECRUITING

    Valencia, 46010, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Fundación Alcorcón

    NOT_YET_RECRUITING

    Alcorcón, Madrid, 28922, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Nuestra Señora del Perpétuo Socorro

    RECRUITING

    Albacete, 02006, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Reina Sofía

    NOT_YET_RECRUITING

    Córdoba, 14004, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Severo Ochoa

    NOT_YET_RECRUITING

    Leganés, Madrid, 28914, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario de Burgos

    RECRUITING

    Burgos, 09006, Spain

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.